Why is "Pharmaceutical Research and Manufacturers of America" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-01 19:40:36
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is an American trade group representing companies in the pharmaceutical industry. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, D.C.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Trump has battled the drug industry. Now its top lobbyist is leaving. - The Washington Post
-
Pharmaceutical Research and Manufacturers of America (PhRMA) on President Trump’s Tariffs on Pharmaceuticals, Says, “Tariffs On Cutting-Edge Medicines Will Increase Costs And Could Jeopardize Billions In U.S. Investments Announced In The Last Year” - Sierra Sun Times
-
Healthcare lobbying surge in 2025 led by PhRMA, AHA - Modern Healthcare
-
Pharmaceutical Research and Manufacturers of America (PhRMA) on Compounding Concerns, Says, “Mass Compounding Of New Medicines Weeks After Their Approvals Undermines The Public Health And The Entire Drug Review And Approval Framework” - Sierra Sun Times
-
PhRMA Announces Major Actions as Part of Industry’s Commitment to American Patients and Workers - PhRMA
-
Pharma poised for big win over PBMs - The Washington Post
-
PhRMA on President Trump’s State of the Union Address, Says, “Government-Imposed Most Favored Nation Policies Would Undermine U.S. Competitiveness While Doing Nothing To Address Insurance Practices That Deny Care And Raise Costs For Patients” - Sierra Sun Times
-
PhRMA Statement on Today's White House Announcement - PhRMA
-
PhRMA joins legal battle over Inflation Reduction Act's 'price-setting' measures - Fierce Pharma
-
PhRMA Statement on Most Favored Nation Executive Order - PhRMA
-
PhRMA launches ad campaign targeting 340B drug discount program - Modern Healthcare
-
PhRMA Statement on ACIP Meeting - PhRMA
-
PhRMA Statement on the 2024 U.S. Election - PhRMA
-
PhRMA Comments to U.S. Department of Commerce on 232 Investigation - PhRMA
-
Medicines in Development for Chronic Illness Older Americans 2023 Report - PhRMA
-
PhRMA Principles on Conduct of Clinical Trials - PhRMA
-
PhRMA’s Steve Ubl Congratulates Robert F. Kennedy Jr. - PhRMA
-
PhRMA Files Amicus Brief with the U.S. Supreme Court in Support of FDA - PhRMA
-
Direct to Consumer Advertising Principles - PhRMA
-
Industry Economic Impact - PhRMA
-
PhRMA Statement on Government Price Setting in Medicare Part D - PhRMA
-
PhRMA Loses Another Legal Battle as Court Sides with Arkansas Over Drug Discount Program - BioSpace
-
2 years after leaving PhRMA, AstraZeneca opts back in - Fierce Pharma
-
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations - CNBC
-
Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds - Reuters
-
Purdue trustee Dave Ricks named 2025 CEO of the Year - Purdue University
-
Stephen Ubl - Modern Healthcare
-
Trump pharma tariffs would raise U.S. drug costs by $51 billion annually, report finds - CNBC
-
Pharma Group Tells Justices Oregon Law Threatens Trade Secrets - Bloomberg Law News
-
Big Pharma pushes repeal of drug price negotiation that lowers costs for consumers - The Michigan Independent
-
Drugmakers Warn Justices Oregon Pricing Law Risks Secrets - Law360
-
Texas Court Dismisses PhRMA IRA Lawsuit Against Biden Administration - BioSpace
-
Split 9th Circ. Upholds Oregon Pharmaceutical Reporting Law - Law360
-
Elevance Health, Centene donated to Trump inaugural fund, key lawmakers - Fierce Healthcare
-
Health sector gave millions to Trump inauguration - Modern Healthcare
-
Pharma group leader says Dems who vote for reconciliation bill 'won't get a free pass' - Politico
-
Appeals Court resurrects PhRMA's lawsuit challenging pricing provisions in IRA - Fierce Pharma
-
Article | The health care industry is investing big — in lobbying - POLITICO Pro
-
PhRMA Updates its Code on Interactions with Health Care Professionals in Response to the OIG's Special Fraud Alert on Speaker Programs - Mintz
-
With Vaccines, Big Pharma Has a Chance to Fix Its Reputation - ADWEEK
-
Oregon drug pricing transparency law survives constitutional challenge, US appeals court says - Reuters
-
PhRMA Joins Merck, BMS in Latest Lawsuit Challenging IRA’s Drug Price Negotiations - BioSpace
-
Daniel Perez stacks $490K to defend HD 116 in best fundraising month this cycle - Florida Politics
-
PhRMA Responds to HHS DTC Rule, Launches Website Providing Patients with Cost Information - BioSpace
-
AstraZeneca follows AbbVie, Teva in surprising departure from lobbying group PhRMA - Fierce Pharma
-
Pharmaceutical Industry Urges Better K-12 STEM Education to Close Skills Gap & Avoid Worker Shortage - The 74
-
Trump tells big pharma to cut their ‘astronomical’ drug prices - marketplace.org
-
Pharmaceutical Industry Is Developing Almost 800 Chronic Disease Drugs - TechTarget
-
Lobbying compensation reports show Rich Heffley’s firm enjoyed a healthy Q2 - Florida Politics
-
PhRMA Member Companies Invested $58.8 Billion In R&D In 2015 - BioSpace
-
Drug firms have to stop paying doctors - CNN
-
Top Lobbyist for Drug Makers Threads a Thicket of Outrage (Published 2016) - The New York Times
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.